The present invention relates generally to a peripheral marker or marker of blood
brain barrier integrity and methods of using them in the diagnosis, prognosis,
and treatment of a variety of diseases. The preferred embodiments of the present
invention relate to methods, compositions, kits, and assays useful in determining
the integrity or permeability of a blood brain barrier. The various embodiments
of the present invention can be used to identify subjects at risk for developing
a disease associated with increased permeability of the blood brain barrier, as
well as to provide insight on the ability of an agent or agents to pass the blood
brain barrier. Preferably, increased levels of S100 protein are used alone
or in combination with other markers of diseased state in order to diagnose and
prognosticate permeability of the BBB.
